Prophase labs announces filing of definitive proxy statement and new date for special meeting of shareholders

Uniondale, ny, aug. 19, 2025 (globe newswire) -- prophase labs, inc. (nasdaq: prph) (the “company” or “prophase”), a next generation biotech, genomics and consumer products company, today announced that it filed a definitive proxy statement (“def 14a”) with the u.s. securities and exchange commission (“sec”) on friday, august 15, 2025 and received a “no further comments” letter from the sec's division of corporation finance office of life sciences, indicating that the staff had completed the review of the preliminary proxy statement of schedule 14a, on monday, august 18, 2025.
PRPH Ratings Summary
PRPH Quant Ranking